Published this week in The Lancet Diabetes & Endocrinology , the research findings looked at 11 large-scale trials investigating seven medications in the GLP-1 receptor agonist class, including semaglutide (sold as Ozempic or Wegovy), dulaglutide (sold as Trulicity), and liraglutide (sold as Victoza)
What type of medical monitoring is recommended
Neurology 58:13959, PMID: 12011287 Deth R, Muratore C, Benzecry J, Power-Charnitsky VA, Waly M (2008)) How environmenta and genetic factors combine to cause autism: a redox/methylation hypothesis
no major interactions, but consult a doctor if on medications (e.g., thyroid hormone or anticoagulants)
Global demand for GLP1 therapies has highlighted the critical need for delivery systems that enable safe, accurate, and consistent dosing for patients